Explore our industrial-grade extrusion platforms, engineered for exacting micro-bore medical fluid sets, specialized automotive conduits, and continuous downstream finishing operations.
In modern intensive care units, oncology infusion clinics, and general hospital wards, the single-use intravenous (IV) infusion set serves as the primary conduit for life-sustaining therapeutic fluids, parenteral nutrition, and blood products. Because pharmaceutical solutions vary drastically in molecular weight, lipophilicity, and sensitivity to ultraviolet and visible light, the mechanical and rheological demands placed upon the infusion tube have grown exponentially. Today, the global disposable medical tubing market demands extrusion lines capable of running at ultra-high linear speeds (up to 300 meters per minute) while holding strict outer diameter (OD) and wall concentricity tolerances within ±0.01 mm.
Historically, Tier-1 medical device corporations relied almost exclusively on Western European machinery to achieve this level of repeatability. However, over the past twenty-five years, Jiangsu Baodie Automation Equipment Co., Ltd. (BAOD EXTRUSION)—originating with deep Taiwanese mechanical foundations dating back to the KINGSWEL GROUP in the 1980s—has fundamentally re-engineered the precision medical extrusion paradigm. Combining high-grade Japanese alloy steels, proprietary screw flight geometries, zero-backlash servomotors, and multi-axis laser gauging, China-manufactured infusion tube extrusion lines now compete head-to-head with top-tier international machinery at a superior total cost of ownership (TCO).
Furthermore, stringent global regulatory frameworks, including the European Union Medical Device Regulation (EU MDR 2017/745) and the United States FDA 21 CFR Part 820, have accelerated the phase-out of traditional plasticizers such as di(2-ethylhexyl) phthalate (DEHP). This chemical shift necessitates the processing of alternative compounding resins—such as non-DEHP plasticized PVC, Thermoplastic Polyurethane (TPU), Thermoplastic Elastomers (TPE), and multi-layer polyolefin co-extrusions. Extrusion lines must now deliver exact thermal control, non-pulsating melt flows, and cleanroom compatibility to avoid degradation, melt fracture, or erratic shrinkage during continuous 24/7 manufacturing operations.
| Performance Characteristic | Legacy PVC Infusion Extrusion Line | BAOD High-Speed Cleanroom Infusion Line | Clinical & Manufacturing Benefit |
|---|---|---|---|
| Resin Compatibility | Standard Plasticized PVC only | Non-DEHP PVC, Medical TPU, TPE, PP/PE Co-ex | Eliminates phthalate leaching; broad pharmaceutical compatibility |
| Linear Production Velocity | 50 – 90 m/min | 150 – 300 m/min continuous | 200%–300% throughput increase per square meter of cleanroom |
| OD / ID Dimensional Drift | ±0.05 mm to ±0.08 mm | ±0.01 mm (Closed-loop laser auto-compensation) | Automated solvent bonding; zero leakages at lure lock interfaces |
| Cleanroom Environmental Rating | Standard industrial frame; unsealed drive | 304/316L Stainless Steel chassis; ISO Class 7/8 compliant | Zero airborne particulate emission; wipe-down chemical resistance |
| Downstream Integration | Manual coiling or rudimentary flying shear | Fully servo-synchronized dual coiler or rotary cutter | Tension-controlled packaging preventing tube ovalization/kinking |
Every sub-assembly is built under rigorous metallurgical and automation standards to ensure steady laminar flow, instantaneous heat evacuation, and flawless surface finish.
Equipped with an optimal 28:1 or 30:1 L/D ratio single-screw barrel machined from nitrided 38CrMoAlA or premium bimetallic alloys. The custom barrier flight design guarantees homogeneous plasticization without thermal degradation of shear-sensitive medical compounds.
Manufactured from imported German DIN 1.2083 ESR stainless steel, vacuum-hardened to HRC 52–55 and mirror-polished to Ra < 0.02 μm. Spiral mandrel and crosshead distributors eliminate weld lines and dead zones, enabling rapid color purge and uniform multi-layer wall distribution.
Fabricated entirely from electropolished SUS304/SUS316L stainless steel. The primary vacuum calibration stage utilizes high-accuracy water rings and vortex spray cooling to prevent tube ovalization under high-speed puller forces.
Our servo-driven caterpillar puller utilizes ultra-soft, wear-resistant medical silicone belts to prevent outer surface marring or deformation. Real-time feedback from dual-axis or four-axis laser diameter gauges auto-modulates puller speed.
Engineered for continuous production without slowing or stopping the extrusion line. The system manages constant-tension traversing and features automatic pneumatic spool-switching and pneumatic cut-and-clamp mechanisms.
Centralized industrial touch screen featuring intuitive graphical plant schematics. Supports multi-recipe storage, real-time diagnostic reporting, cloud IoT remote connectivity, and complete data integrity protocols.
Infusion sets have diverged into highly specialized clinical subsets. BAOD extrusion platforms offer modular crosshead tooling and multi-extruder configurations tailored to specific clinical protocols.
Widely deployed in outpatient and inpatient general wards. The extrusion line is tuned for maximum operational economy, operating continuously at speeds between 180 and 260 m/min with minimal maintenance.
Critical for delivering chemotherapeutic agents (e.g., Paclitaxel, Cisplatin) and photosensitive vitamins that break down under ambient hospital lighting.
Lipophilic pharmaceutical formulations adsorb rapidly onto standard PVC walls, leading to dangerous clinical under-dosing. Our specialized TPE/TPU lines process olefinic block copolymers without surface delamination.
Neonatal and pediatric intensive care units require ultra-low priming volumes. Tubes must withstand mechanical pressures generated by electronic volumetric infusion pumps without lumen collapse or ballooning.
How BAOD combines Taiwanese machine-tool lineage with the Yangtze River Delta’s high-tech industrial cluster to deliver unmatched production reliability and commercial value.
Unlike simple assemblers who outsource critical components, BAOD houses multi-axis CNC machining centers, wire EDM, and cryogenic metallurgical treating equipment within our Haian, Nantong base. We manufacture over 85% of critical line components in-house, ensuring absolute structural alignment and die-surface perfection.
We blend competitive Chinese manufacturing economics with globally trusted electrical and pneumatic systems. Standard line configurations integrate Siemens/Schneider low-voltage components, Omron/Mitsubishi programmable controllers, NSK/SKF ultra-precision bearings, and SEW-Eurodrive helical gear units for total overseas peace of mind.
While European lead times frequently exceed 9 to 14 months, BAOD delivers fully configured, factory-acceptance-tested (FAT) extrusion lines within 60 to 90 business days. Our massive inventory of modular frames, pre-turned screws, and rough-machined heads enables rapid scaling for large international tenders.
We invite medical device engineering teams to send their own proprietary raw resin pellets to our Nantong testing center. We will conduct full line trials, analyze melt stability, run 3-hour continuous extrusion cycles, and deliver comprehensive Cpk laser measurement reports before you finalize purchase commitments.
Book a Factory Material TrialThe convergence of artificial intelligence, sustainable biopolymers, and sub-micron sensing is driving the next generation of medical tubing equipment.
High-speed line cameras equipped with deep-learning neural models detect gels, black specks, micro-bubbles, and pinholes down to 10 μm at 300 m/min. Defective sections are logged with spatial timestamps and automatically rejected downstream without operator intervention.
Integrating real-time ultrasonic melt viscosity sensors directly into the extruder barrel. The AI algorithm predicts polymer molecular degradation and dynamically balances barrel temperature zones to maintain steady melt output despite variations in regrind or raw resin batch lots.
As global carbon regulations tighten, healthcare institutions are piloting bio-based polyesters (PHA, PLA blends) and bio-TPUs. BAOD’s metallurgical R&D is formulating low-shear screw flights to process these thermally fragile, narrow-window polymers without hydrolytic degradation.
A medical extrusion line is only as viable as its ability to satisfy strict pharmaceutical and medical device validation audits.
BAOD supplies fully documented validation protocols compliant with GAMP 5 principles to streamline client qualification processes:
Every BAOD infusion line features mechanical engineering tailored specifically for cleanroom environments:
Our commitment extends across the entire equipment lifecycle through our structured Global Service program:
In-depth engineering answers addressing screw design, line stability, material transitions, and cleanroom qualification.
In addition to standard medical infusion sets, BAOD manufactures high-speed composite extrusion platforms and specialized downstream units for rigorous industrial environments.